BioSpace News Archive

VolitionRx Limited (NYSE AMERICAN: VNRX) (“Volition”), in collaboration with researchers at the University of Namur and QUALIblood in Belgium has published a poster presentation entitled “Evaluation and comparison of NETosis biomarkers in sepsis and COVID-19 patients” at the International Society on Thrombosis and Haemostasis (ISTH) Congress earlier this week.

Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to release financial results for its second quarter and six month periods ended June 30, 2022 before market open on Thursday, August 11, 2022.

Debbie’s Dream Foundation: Curing Stomach Cancer and the Korean Cancer Association hosted the 2nd International Gastric Cancer Educational Symposium for Patients on Thursday, June 16, 2022.

SoniVie announced that on May 30th 2022 the first patient was treated with its Renal Artery Denervation TIVUS™ technology, as part of the recently FDA IDE-approved Pilot study to treat Hypertension.

Blastomycosis is an infection by the parasitic fungi called Blastomyces that lives mainly in the decomposing matter such as soil, leaves, and wood.

Wilmington, Delaware, United States, Transparency Market Research Inc.: Atopic dermatitis, a type of eczema, is the most common and long-term inflammatory skin condition.

Wilmington, Delaware, United States, Transparency Market Research Inc.: This report analyzes the current scenario and future growth prospects of the global viral vector & plasmid DNA manufacturing market.

The global thalassemia market is projected to grow at a favorable rate from 2021 to 2031. The expanding population, increased need for improved curative gene treatments, and increased awareness of existing treatment choices are the primary aspects expected to drive the worldwide thalassemia market during the forecast period.

Wilmington, Delaware, United States, Transparency Market Research Inc.: A large extent of new developments in the neurovascular devices market stems from strides made in endovascular treatment.

Nihon Kohden OrangeMed, Inc. received U.S. Food and Drug Administration (FDA) 510(k) clearance for its NKV-330 Ventilator System.